Dapoxetine: A novel, fast-acting serotonin reuptake inhibitor

Formulary

Volumn 40, Issue 7, 2005, Pages 227-230

  Feret, Brett ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CLOMIPRAMINE; CYTOCHROME P450; DAPOXETINE; EMLA; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TADALAFIL;

AREA UNDER THE CURVE; CLINICAL TRIAL; DIARRHEA; DIZZINESS; DRUG ABSORPTION; DRUG ALCOHOL INTERACTION; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; HEADACHE; HUMAN; MULTIPLE DRUG DOSE; NAUSEA; PREMATURE EJACULATION; REVIEW; SINGLE DRUG DOSE;

EID: 23144463098     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision). Washington, DC: American Psychiatric Association; 2000.
2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537-544.
3. Montague DK, Jarow J, Broderick GA, et al, and the AUA Erectile Dysfunction Guideline Update Panel. AUA Guideline on the Pharmacologic Management of Premature Ejaculation. J Urol. 2004;172:290-294.
4. Johnson & Johnson Press Releases & Statements. New Drug Application Submitted for Dapoxetine for Premature Ejaculation. Available at: http://www.jnj.com/news/jnj_news/20041228_115 004.htm. Accessed June 20, 2005.
5. Sorbera LA, Castaner J, Castaner RM. Dapoxetine hydrochloride. Drugs Future. 2004;29: 1201-1205.
6. McMahon C. Pharmacological Treatment of Ejaculatory Disorders. J Sex Med. 2004;1(Suppl 1):19-21.
7. Gengo PJ, Giuliano F, McKenna K, et al. Monoaminergic transport binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation [abstract]. Presented at: the 100th American Urological Association Annual Meeting; May 21-26, 2005; San Antonio,Texas. Abstract 878.
8. Dresser M, Lindert K, Lin D, et al. Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers [abstract]. Clin Pharmacol Ther. 2004;75(2):113. Abstract P1.
9. Hellstrom W, Gittelman M, Althof S, et al. Dapoxetine HCl for the treatment of premature ejaculation: a phase II, randomized, double-blind, placebo-controlled study [abstract]. J Sex Med. 2004;Suppl 1:59. Abstract 097.
10. Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation [abstract]. Presented at: the 100th American Urological Association Annual Meeting; May 21-26, 2005; San Antonio, Texas. Abstract 740.
11. Hellstrom W, Althof S, Gittelman M, et al. Dapoxetine for the treatment of men with premature ejaculation (PE):dose-finding analysis [abstract]. Presented at: the 100th American Urological Association Annual Meeting; May 21-26, 2005; San Antonio, Texas. Abstract 877.
12. Dresser M, Jazrawi RP, Desai D, Modi NB. Dapoxetine for the treatment of premature ejaculation: Lack of interaction with PDE5 inhibitors [abstract]. Presented at: the 100th American Urological Association Annual Meeting; May 21-26, 2005; San Antonio, Texas. Abstract 739.
13. Modi NB, Dresser M, Desai D, Jazrawi RP. Dapoxetine for the treatment of premature ejaculation: lack of interaction with ethanol [abstract]. Presented at: the 100th American Urological Association Annual Meeting; May 21-26, 2005; San Antonio, Texas. Abstract 879.